By Justin Petrone

Demand for NimbleGen microarrays and 454 Life Sciences sequencers helped Roche Applied Science's sales rise 8 percent in the first half of this year, Roche said last week.

Roche Diagnostics' Applied Science business, which includes the two firms, posted CHF 403 million ($376 million) in sales for the first half of 2009.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.